Organ | Training data | Validation data | Test data | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | % | Errors | % | No. | % | Errors | % | No. | % | Errors | % | |
Primary carcinoma | 232 | 41.3% | 42 | 18.1% | 163 | 42.7% | 25 | 15.3% | 89 | 54.3% | 7 | 7.9% |
Metastatic carcinoma | 151 | 26.9% | 39 | 25.8% | 98 | 25.7% | 26 | 26.5% | 19 | 11.6% | 4 | 21.1% |
Benign (normal) lesion | 33 | 5.9% | 4 | 12.1% | 22 | 5.8% | 3 | 13.6% | 13 | 7.9% | 1 | 7.7% |
Benign mesenchymal tumor | 120 | 21.4% | 28 | 23.3% | 80 | 20.9% | 24 | 30.0% | 24 | 14.6 | 4 | 16.7% |
Malignant mesenchymal tumor | 26 | 4.6% | 8 | 30.8% | 19 | 5.0% | 6 | 31.6% | 19 | 11.6% | 2 | 10.5% |
 | 562 | 100.0% | 121 | 21.5% | 382 | 100.0% | 84 | 22.0% | 164 | 100% | 18 | 11% |